{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:19:57Z","timestamp":1771654797593,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tracli.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:35:48Z","timestamp":1611858948000},"page":"191-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acquired factor V inhibitor: Success of steroids in a patient with primary sclerosing cholangitis, ulcero haemorragic rectocolitis, biological Biermer's disease"],"prefix":"10.1016","volume":"28","author":[{"given":"F.","family":"Pineau-Vincent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Toulon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Laribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.01.004_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0950-3536(98)80050-4","article-title":"Acquired factor V inhibitors","volume":"11","author":"Kn\u00f6bl","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.tracli.2021.01.004_bib0010","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.revmed.2010.06.008","article-title":"Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations","volume":"32","author":"Alcantara","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.tracli.2021.01.004_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00001721-199402000-00015","article-title":"Severe bleeding caused by an inhibitor to coagulation factor V: a case report","volume":"5","author":"Smid","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tracli.2021.01.004_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2141.2009.07708.x","article-title":"Advances in understanding the bleeding diathesis in factor V deficiency","volume":"146","author":"Duckers","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2021.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1055\/s-0037-1615962","article-title":"Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding","volume":"85","author":"Izumi","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tracli.2021.01.004_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.revmed.2018.03.160","article-title":"Apparition d\u2019anticorps anti facteur V apr\u00e8s un traitement par clindamycine\u00a0: \u00e0 propos d\u2019un cas et revue de la litt\u00e9rature","volume":"39","author":"Jarrin","year":"2018","journal-title":"Rev Med Int"},{"key":"10.1016\/j.tracli.2021.01.004_bib0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11239-010-0529-6","article-title":"Acquired factor V inhibitors:a systematic review","volume":"31","author":"Franchini","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.tracli.2021.01.004_bib0040","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1160\/TH08-11-0767","article-title":"Acquired factor V inhibitor. A problem-based systematic. review","volume":"101","author":"Ang","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tracli.2021.01.004_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00001721-200412000-00003","article-title":"Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation","volume":"15","author":"Favaloro","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tracli.2021.01.004_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/hae.12915","article-title":"Successfull treatment of chronic recurrent life-threatening bleeding to an acquired factor V inhibitor with rituximab and steroids","volume":"22","author":"Patel","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.tracli.2021.01.004_bib0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MBC.0b013e3283001d49","article-title":"Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor","volume":"19","author":"William","year":"2008","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:23Z","timestamp":1761129563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1246782021000227"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.01.004","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired factor V inhibitor: Success of steroids in a patient with primary sclerosing cholangitis, ulcero haemorragic rectocolitis, biological Biermer's disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}